Ambulatory oximetry fails to predict survival in chronic obstructive pulmonary disease with mild-to-moderate hypoxaemia

Respirology

Volumn 18, Issue 2, 2013, Pages 377-382

  Trauer, James M ^a   Gielen, Chelsea A ^b   Aminazad, Ali ^c   Steinfort, Christopher L ^c  

^a WESTERN HOSPITAL   (Australia)

^b BARWON HEALTH   (Australia)

^c Eastern Health Victoria ^*  (Australia)

Author keywords

blood gas analysis; blood gas monitoring; chronic obstructive pulmonary disease; oxygen inhalational therapy; transcutaneous oximetry

Indexed keywords

AGED; AMBULATORY CARE; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMMUNITY LIVING; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPOXEMIA; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; OXIMETRY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

AGED; AGED, 80 AND OVER; ANOXIA; BIOLOGICAL MARKERS; BLOOD GAS ANALYSIS; COMORBIDITY; FEMALE; HUMANS; MALE; MONITORING, AMBULATORY; OXIMETRY; OXYGEN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84872902506     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12010     Document Type: Article

References (30)

1. Nocturnal Oxygen Therapy Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial. Ann. Intern. Med. 1980; 93: 391-398.
2. Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1: 681-686.
3. Tarpy SP, Celli BR,. Long-term oxygen therapy. N. Engl. J. Med. 1995; 333: 710-714.
4. Gõrecka D, Gorzelak K, Sliwiński P, et al. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxia. Thorax 1997; 52: 674-679. (Pubitemid 27404979)
5. Chaouat A, Weitzenblum E, Kessler R, et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur. Respir. J. 1999; 14: 1002-1008.
6. Fletcher EC, Luckett RA, Goodnight-White S, et al. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. Am. Rev. Respir. Dis. 1992; 145: 1070-1076.
7. McDonald CF, Crockett AJ, Young IH,. Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand. Med. J. Aust. 2005; 182: 621-626. (Pubitemid 40932331)
8. Croxton TL, Bailey WC,. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am. J. Respir. Crit. Care Med. 2006; 174: 373-378. (Pubitemid 44223116)
9. Stoller JK, Panos RJ, Krachman S, et al.; Long-term Oxygen Treatment Trial Research Group. Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. Chest 2010; 138: 179-187.
10. Effectiveness of long-term oxygen therapy in treating people with chronic obstructive pulmonary disease (the Long-term Oxygen Treatment Trial [LOTT]). Available from URL: http://clinicaltrials.gov/ct2/show/NCT00692198?term= nct00692198&rank=1 (accessed 15 Jan 2012).
11. American Thoracic Society/European Respiratory Society. Standards for the diagnosis and management of patients with COPD. Position paper 2004: 79. Available from URL: http://www.thoracic.org/clinical/copd-guidelines/resources/ copddoc.pdf (accessed 11 Jan 2012).
12. Tiep BL,. Disease management of COPD with pulmonary rehabilitation. Chest 1997; 112: 1630-1656. (Pubitemid 28007773)
13. Güell Rous R,. Long-term oxygen therapy: are we prescribing appropriately? Int J Chron Obstruct Pulmon Dis 2008; 3: 231-237.
14. Casanova C, Hernández MC, Sánchez A, et al. Twenty-four-hour ambulatory oximetry monitoring in COPD patients with moderate hypoxaemia. Respir. Care 2006; 51: 1416-1423.
15. Trauer JM, Gielen C, Trauer T, et al. Inability of single resting arterial blood gas to predict hypoxaemia in COPD. Intern. Med. J. 2012; 42: 387-394.
16. Toraldo D, Nicolardi G, De Nuccio F, et al. Pattern of variables describing desaturator COPD patients, as revealed by cluster analysis. Chest 2005; 128: 3828-3837. (Pubitemid 43062642)
17. Lewis CA, Fergusson W, Eaton T, et al. Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Thorax 2009; 64: 133-138.
18. Sliwiński P, Lagosz M, Gõrecka D, et al. The adequacy of oxygenation in COPD patients undergoing long-term oxygen therapy assessed by pulse oximetry at home. Eur. Respir. J. 1994; 7: 274-278. (Pubitemid 24137992)
19. Celli B, Decramer M, Kesten S, et al.; UPLIFT Study Investigators. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2009; 180: 948-955.
20. Sinex JE,. Pulse oximetry: principles and limitations. Am. J. Emerg. Med. 1999; 17: 59-67.
21. Ortega R, Hansen CJ, Elterman K, et al. Videos in clinical medicine. Pulse oximetry. N. Engl. J. Med. 2011; 364: e33.
22. Casanova C, de Torres JP, Aguirre-Jaíme A, et al. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Am. J. Respir. Crit. Care Med. 2011; 184: 1015-1021.
23. Han MK, Postma D, Mannino DM, et al. Gender and chronic obstructive pulmonary disease: why it matters. Am. J. Respir. Crit. Care Med. 2007; 176: 1179-1184. (Pubitemid 350256470)
24. Nizet TA, van den Elshout FJ, Heijdra YF, et al. Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxaemia. Chest 2005; 127: 1904-1910.
25. Celli BR,. Predictors of mortality in COPD. Respir. Med. 2010; 104: 773-779.
26. Celli BR, Cote CG, Lareau SC, et al. Predictors of survival in COPD: more than just the FEV1. Respir. Med. 2008; 102 (Suppl.): S27-35. (Pubitemid 351877093)
27. Ong KC, Earnest A, Lu SJ,. A multidimensional grading system (BODE index) as a predictor of hospitalization in COPD. Chest 2005; 128: 3810-3816. (Pubitemid 43062640)
28. Calverley PM, Anderson JA, Celli B, et al. TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007; 356: 775-789. (Pubitemid 46294610)
29. Tashkin DP, Celli B, Senn S, et al. UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 2008; 359: 1543-1554.
30. Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive pulmonary disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am. J. Respir. Crit. Care Med. 1996; 154: 959-967.